Shares of Shilpa Medicare Ltd had been buying and selling within the inexperienced and 4% greater on 5 Could after the corporate’s Dharwad plant gained EU GMP clearance.
The corporate’s biologics enterprise, Shilpa Biologics, in Dharwad, Karnataka, has gained European GMP accreditation for producing take a look at batches following an inspection carried out by Austria’s competent physique between 18 and 20 February 2025.
The authority of Austria concluded the inspection with zero observations.
The inspection, which included the sterile drug product filling and packaging line, high quality methods, and high quality management laboratories, discovered compliance with Good Manufacturing Observe rules and proposals.
Shilpa Biologicals, the corporate’s subsidiary, signed a binding time period sheet with Switzerland-based mAbTree Biologics AG in March to develop, manufacture, market, and promote a brand new organic entity (NBE).
On 18 September 2024 and 4 June 2024, the share reached a 52-week excessive of Rs 959.95 and a 52-week low of Rs 419.10.
At 12:08 pm, the shares of Shilpa Medicare had been buying and selling 4.48% greater at Rs 658.70 on NSE.
Curious About Shilpa Medicare Ltd? Ask the Analyst.
Unlock worthwhile alternatives every single day! Unicorn Indicators supplies actionable intraday buying and selling alerts for shares and futures. Don’t miss out – obtain Unicorn Indicators and begin profitable now!
